Terms: = Skin cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Diagnosis
55 results:
1. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
2. Review: Are moles senescent?
Bennett DC
Pigment Cell Melanoma Res; 2024 May; 37(3):391-402. PubMed ID: 38361107
[TBL] [Abstract] [Full Text] [Related]
3. COL1A1::PDGFB fusion uterine sarcoma with a tert promoter mutation.
Lu Y; Chen X; Zeng W; Hua P; Shen Y; Qiu Y; He X; Zhang H
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23210. PubMed ID: 37870859
[TBL] [Abstract] [Full Text] [Related]
4. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
5. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract] [Full Text] [Related]
6. Agminated presentation of fusion-driven melanocytic neoplasms.
Fumero-Velázquez M; Hagstrom M; Dhillon S; Olivares S; Jennings LJ; Dittman D; Sukhanova M; Arva NC; Goldstein SD; Theos A; Pavlidakey P; Carr Z; Gerami P
J Cutan Pathol; 2023 Oct; 50(10):913-921. PubMed ID: 37407520
[TBL] [Abstract] [Full Text] [Related]
7. Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases.
Mansour B; Vanecek T; Kastnerova L; Nosek D; Kazakov DV; Donati M
Am J Dermatopathol; 2023 May; 45(5):306-310. PubMed ID: 36939120
[TBL] [Abstract] [Full Text] [Related]
8. tert Promoter Mutational Analysis as an Ancillary Diagnostic Tool for Diagnostically Challenging Melanocytic Neoplasms.
Boutko A; Asadbeigi S; Roth A; Lampley N; Olivares S; Dittmann D; Dittmann D; Jennings L; Gerami P
Am J Dermatopathol; 2023 May; 45(5):289-299. PubMed ID: 36898007
[TBL] [Abstract] [Full Text] [Related]
9. Molecular testing in melanoma for the surgical pathologist.
Andea AA
Pathology; 2023 Mar; 55(2):245-257. PubMed ID: 36653236
[TBL] [Abstract] [Full Text] [Related]
10. Compound clear cell sarcoma with EWSR1::CREM fusion.
Li P; Busam K
J Cutan Pathol; 2023 Dec; 50(12):1065-1069. PubMed ID: 36640048
[TBL] [Abstract] [Full Text] [Related]
11. An update on genomic aberrations in Spitz naevi and tumours.
Hagstrom M; Fumero-Velázquez M; Dhillon S; Olivares S; Gerami P
Pathology; 2023 Mar; 55(2):196-205. PubMed ID: 36631338
[TBL] [Abstract] [Full Text] [Related]
12. Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies.
Zob DL; Augustin I; Caba L; Panzaru MC; Popa S; Popa AD; Florea L; Gorduza EV
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614156
[TBL] [Abstract] [Full Text] [Related]
13. Molecular and immunohistochemical comparison between primary gastrointestinal mucosal melanomas and atypical gastrointestinal stromal tumors.
Song IH; Sung YE; Kang J; Lee A; Lee SH
Pathol Res Pract; 2022 Dec; 240():154189. PubMed ID: 36327823
[TBL] [Abstract] [Full Text] [Related]
14. Clinical and pathological characteristics of familial melanoma with germline tert promoter variants.
Zaremba A; Meier F; Schlein C; Jansen P; Lodde G; Song M; Kretz J; Möller I; Stadtler N; Livingstone E; Zimmer L; Hadaschik E; Sucker A; Schadendorf D; Griewank K
Pigment Cell Melanoma Res; 2022 Nov; 35(6):573-586. PubMed ID: 35912549
[TBL] [Abstract] [Full Text] [Related]
15. Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.
Luo L; Shen R; Arora A; Orlow I; Busam KJ; Lezcano C; Lee TK; Hernando E; Gorlov I; Amos C; Ernstoff MS; Seshan VE; Cust AE; Wilmott J; Scolyer RA; Mann G; Nagore E; Funchain P; Ko J; Ngo P; Edmiston SN; Conway K; Googe PB; Ollila D; Lee JE; Fang S; Rees JR; Thompson CL; Gerstenblith M; Bosenberg M; Gould Rothberg B; Osman I; Saenger Y; Reynolds AZ; Schwartz M; Boyce T; Holmen S; Brunsgaard E; Bogner P; Kuan PF; Wiggins C; Thomas NE; Begg CB; Berwick M;
Pigment Cell Melanoma Res; 2022 Nov; 35(6):605-612. PubMed ID: 35876628
[TBL] [Abstract] [Full Text] [Related]
16. Fatal melanoma with a novel MYO5A-BRAF fusion and small associated conventional nevus: A case report and review of literature.
Clark HE; Huang YYM; Vance GH; Alomari AK
J Cutan Pathol; 2022 Sep; 49(9):808-812. PubMed ID: 35596628
[TBL] [Abstract] [Full Text] [Related]
17. PRAME Expression Correlates With Genomic Aberration and Malignant diagnosis of Spitzoid Melanocytic Neoplasms.
Gerami P; Benton S; Zhao J; Zhang B; Lampley N; Roth A; Boutko A; Olivares S; Busam KJ
Am J Dermatopathol; 2022 Aug; 44(8):575-580. PubMed ID: 35503885
[TBL] [Abstract] [Full Text] [Related]
18. Genetic risk factors in melanoma etiopathogenesis and the role of genetic counseling: A concise review.
Serman N; Vranic S; Glibo M; Serman L; Bukvic Mokos Z
Bosn J Basic Med Sci; 2022 Sep; 22(5):673-682. PubMed ID: 35465855
[TBL] [Abstract] [Full Text] [Related]
19. Elevated non-coding promoter mutations are associated with malignant transformation of melanocytic naevi to melanoma.
Colebatch AJ; Paver EC; Vergara IA; Thompson JF; Long GV; Wilmott JS; Scolyer RA
Pathology; 2022 Aug; 54(5):533-540. PubMed ID: 35248370
[TBL] [Abstract] [Full Text] [Related]
20. Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population.
Church AJ; Moustafa D; Pinches RS; Hawryluk EB; Schmidt BAR
Pediatr Dermatol; 2022 May; 39(3):409-419. PubMed ID: 35194848
[TBL] [Abstract] [Full Text] [Related]
[Next]
